Past, Current, and Future Cancer Clinical Research Collaborations: The Case of the European Organisation for Research and Treatment of Cancer.
Journal
Clinical and translational science
ISSN: 1752-8062
Titre abrégé: Clin Transl Sci
Pays: United States
ID NLM: 101474067
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
04
05
2020
accepted:
14
07
2020
pubmed:
18
8
2020
medline:
26
10
2021
entrez:
18
8
2020
Statut:
ppublish
Résumé
Although collaborations between academic institutions and industry have led to important scientific breakthroughs in the discovery stage of the pharmaceutical research and development process, the role of multistakeholder partnerships in the clinical development of anticancer medicines necessitates further clarification. The benefits associated with such cooperation could be undercut by the conflicting goals and motivations of the actors included. The aim of this review was to identify and characterize past, present, and future stakeholder partnership models in cancer clinical research through the lens of the European Organisation for Research and Treatment of Cancer (EORTC). Based on the analysis of several landmark EORTC trials performed across the span of three decades, four existing models of stakeholder cooperation were delineated and characterized. Additionally, a hypothetical fifth model representing a potential future collaborative framework for cancer clinical research was formulated. These models mainly differ in terms of the nature and responsibilities of the partners included and show that clinical research partnerships in oncology have evolved over time from small-scale academia-industry collaborations to complex interdisciplinary cooperation involving many different stakeholders.
Identifiants
pubmed: 32799428
doi: 10.1111/cts.12863
pmc: PMC7877867
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
47-53Informations de copyright
© 2020 EORTC. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of the American Society of Clinical Pharmacology and Therapeutics.
Références
Nature. 2007 Mar 8;446(7132):137-8
pubmed: 17344833
Ann Oncol. 2018 Dec 1;29(12):2313-2327
pubmed: 30307465
Nat Med. 2009 May;15(5):502-7
pubmed: 19424212
Ann Oncol. 2012 Jun;23(6):1646-51
pubmed: 22048151
N Engl J Med. 2000 May 18;342(20):1516-8
pubmed: 10816191
Eur J Cancer. 2013 Sep;49(13):2777-83
pubmed: 23777742
Expert Opin Drug Discov. 2006 Jun;1(1):1-6
pubmed: 23506026
Drug Discov Today. 2009 Jan;14(1-2):95-101
pubmed: 18992364
J Clin Oncol. 2005 Oct 1;23(28):6854-64
pubmed: 16192577
J Natl Cancer Inst. 2009 Feb 4;101(3):142-52
pubmed: 19176454
Ann Oncol. 2014 Apr;25(4):816-823
pubmed: 24667714
Expert Opin Drug Discov. 2017 Jun;12(6):537-540
pubmed: 28394189
Mol Oncol. 2015 May;9(5):951-9
pubmed: 25888066
Eur Respir J. 2019 Feb 21;53(2):
pubmed: 30792235
Mol Oncol. 2019 Mar;13(3):549-557
pubmed: 30698321
Drug Discov Today. 2015 Dec;20(12):1455-63
pubmed: 26482740
Eur J Cancer. 2013 Jan;49(1):1-7
pubmed: 23079476
ESMO Open. 2017 Aug 3;2(3):e000187
pubmed: 29021919
Blood. 2006 Nov 15;108(10):3295-301
pubmed: 16873669
Drug Discov Today. 2011 Dec;16(23-24):1076-83
pubmed: 21820527
Public Health Genomics. 2015;18(6):338-48
pubmed: 26555355
Sci Eng Ethics. 2003 Jan;9(1):43-8
pubmed: 12645228
Lancet. 2008 Jul 12;372(9633):117-26
pubmed: 18620949
Front Pharmacol. 2020 Feb 05;11:43
pubmed: 32116718
Eur J Cancer. 2017 Nov;86:143-149
pubmed: 28987771
Drug Discov Today. 2012 Oct;17(19-20):1088-102
pubmed: 22627006
Cancer Res. 2008 Nov 1;68(21):8643-53
pubmed: 18974103
Ann Am Thorac Soc. 2013 Feb;10(1):31-8
pubmed: 23509330
Ann Oncol. 2017 Dec 1;28(12):3000-3008
pubmed: 28950372
Ann Oncol. 2010 Aug;21(8):1573-1578
pubmed: 20133383
J Clin Oncol. 2006 Apr 1;24(10):1590-6
pubmed: 16575010
BMJ. 2019 Jul 10;366:l4340
pubmed: 31292109
PLoS Med. 2016 Jun 21;13(6):e1002049
pubmed: 27328301
Eur J Cancer. 2005 Oct;41(15):2206-9
pubmed: 16162405
Mol Oncol. 2019 Mar;13(3):558-566
pubmed: 30561901
Nature. 2001 Jan 11;409(6817):119
pubmed: 11196604
J Clin Oncol. 2008 Nov 20;26(33):5458-64
pubmed: 18955452
J Natl Cancer Inst. 1996 Jul 3;88(13):890-9
pubmed: 8656441
Ther Innov Regul Sci. 2016 May;50(3):347-354
pubmed: 30227070
J Oncol Pract. 2008 May;4(3):140-1
pubmed: 20856620
JAMA. 2003 Feb 12;289(6):741-6
pubmed: 12585953
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Nat Rev Clin Oncol. 2014 Aug;11(8):492-8
pubmed: 24935010
Value Health. 2014 Jun;17(4):471-5
pubmed: 24969009